申请人:Ciba-Geigy Corporation
公开号:US04027029A1
公开(公告)日:1977-05-31
Compounds of the class of 6-phenyl-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carboxamides, their 5-oxides and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties and are active ingredients for therapeutic compositions. In particular, these new compounds have an anti-convulsive and anti-aggressive action and inhibit somatic reflexes. Specific embodiments are N,N-dimethyl-6-phenyl-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-c arboxamide, 6-(o-fluorophenyl)-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodiazepine-2-carb oxamide, N,N-dimethyl-6-(o-fluorophenyl)-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodia zepine-2-carboxamide and N,N-dimethyl-6-(o-chlorophenyl)-8-chloro-4H-s-triazolo[1,5-a][1,4]benzodia zepine-2-carboxamide.
6-苯基-4H-s-三唑并[1,5-a][1,4]苯二氮杂蒽啉-2-羧酰胺类化合物,它们的5-氧化物及其药用可接受的酸盐具有宝贵的药理学性质,并且是治疗组合物的活性成分。具体而言,这些新化合物具有抗惊厥和抗攻击作用,并抑制体性反射。具体实施例包括N,N-二甲基-6-苯基-8-氯-4H-s-三唑并[1,5-a][1,4]苯二氮杂蒽啉-2-羧酰胺,6-(邻氟苯基)-8-氯-4H-s-三唑并[1,5-a][1,4]苯二氮杂蒽啉-2-羧酰胺,N,N-二甲基-6-(邻氟苯基)-8-氯-4H-s-三唑并[1,5-a][1,4]苯二氮杂蒽啉-2-羧酰胺和N,N-二甲基-6-(邻氯苯基)-8-氯-4H-s-三唑并[1,5-a][1,4]苯二氮杂蒽啉-2-羧酰胺。